CapsoVision, Inc
CV Nasdaq· Electromedical & Electrotherapeutic Apparatus
Last close · Oct 26, 2026
$6.89
KIRA · Stoqly’s AI analyst, in plain words
- CapsoVision, Inc had $13.6M of revenue in fiscal 2025, up 15.3% on the year before.
- Its operating margin was −188.3%, down 18.8 pts: of every 100 in sales, about −188 is left after running the business.
- CapsoVision, Inc lost $25.3M in fiscal 2025.
- Free cash flow was −$23.0M in fiscal 2025, −169.4% of revenue.
Market cap
$344M
P/E
2.2x
Revenue
$13.6M
Net income
−$25.3M
Free cash flow
−$23.0M
Operating margin
−188.3%
CapsoVision, Inc in 30 seconds · fiscal 2025
Are sales growing?
+15.3%
Yes. Sales grew 15.3% last year.
Does it make a profit?
−186.8%
No. It lost money last year.
Does profit turn into cash?
−169.4%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
How is the share priced?
2.2x
One share costs 2.2 times its yearly profit per share.
What CapsoVision, Inc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 26, 2026
- Legal name
- CapsoVision, Inc
- CIK
- 0001378325
CapsoVision, Inc · CV
Results and finances
The last 2 fiscal years. Amounts in USD.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Sales and profit | ||
| Revenue | $11.8M | $13.6M |
| Revenue growth | — | 15.3% |
| Gross margin | 54.2% | 52.9% |
| Operating margin | −169.4% | −188.3% |
| Net income | −$19.9M | −$25.3M |
| Net margin | −169.3% | −186.8% |
| Diluted EPS | −$9.85 | −$1.03 |
| Cash | ||
| Cash from operations | −$20.1M | −$22.9M |
| Capital expenditure | $0.2M | $0.1M |
| Free cash flow | −$20.2M | −$23.0M |
| FCF margin | −172.2% | −169.4% |
| Share count change | — | 1,115.6% |
| Debt and strength | ||
| Shareholders' equity | −$130M | $13.3M |
| Current ratio | 8.2x | 3.8x |
| Returns and quality | ||
| Return on tangible equity | — | −190.9% |
| Piotroski F-score | — | 2 |
| Altman Z'' | −78.8 | −30.1 |
Insiders bought, 12 months
$16.0M
2 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
CapsoVision, Inc · CV
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $6.89 a share, the company is worth $344M: 2.2 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001378325). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.